PatternsRadar
Sign in

MAXHEALTHMax Healthcare Institute Limited

NSEF&O
Full chart
902.50INR-14.50 (-1.58%)Close · 6 Oct 2026
13 Aug 2026Last results
HealthcareSector
Healthcare ServicesIndustry
₹87,841 CrMarket cap
60.3P/E (TTM)
49.7%Delivery

Filings & corporate actions

25 results filed
CSV
Next results · Q2 FY27
Expected 1 Nov 2026 – 14 Nov 2026
Estimate: filed 32–45 days after quarter end, last 5 times
Dividend
₹2.00 per share · last 3 Jul 2026
2026
  • 13 AugresultsResults · Q1 FY27 · consolidated and standalone-0.5%NSE
  • 17 JulshareholdingShareholding · 30 Jun 2026-0.8%NSE
  • 3 JuldividendDividend · ₹2.00 per share+2.3%
  • 21 MayresultsResults · Q4 FY26 · consolidated and standalone-6.2%NSE
  • 20 AprshareholdingShareholding · 31 Mar 2026+0.4%NSE
  • 5 FebresultsResults · Q3 FY26 · consolidated and standalone+1.5%NSE
  • 15 JanshareholdingShareholding · 31 Dec 2025+0.3%NSE

Reaction to results · all yearsrose on day 0 in 13 of 24 CSV

QuarterFiledDay 0+5D+20DRel vol
Q1 FY2713 Aug 2026-0.5%-1.3%+2.4%2.4×
Q4 FY2621 May 2026-6.2%-14.0%+0.4%6.4×
Q3 FY265 Feb 2026+1.5%+3.7%+1.6%1.2×
Q2 FY2614 Nov 2025+1.7%+4.8%-1.6%2.4×
Q1 FY2613 Aug 2025+0.5%-0.8%-6.1%2.0×
Q4 FY2520 May 2025-1.9%-1.3%+1.5%0.9×
Q3 FY2530 Jan 2025+1.8%+14.1%-0.9%2.1×
Q2 FY255 Nov 2024+3.4%-4.1%+4.9%1.1×
Q1 FY251 Aug 2024+0.2%-5.1%-6.5%0.5×
Q4 FY2422 May 2024-4.2%-6.9%+10.7%1.1×
Q3 FY2431 Jan 2024+6.0%+13.0%+15.6%2.0×
Q2 FY246 Nov 2023+0.6%-0.2%+10.5%0.8×
Q1 FY247 Aug 2023-4.1%-8.8%+0.9%1.5×
Q4 FY2317 May 2023+2.9%+9.8%+14.9%1.8×
Q3 FY232 Feb 2023-1.2%-0.8%-3.5%1.8×
Q2 FY231 Nov 2022+1.5%+0.4%-1.2%2.4×
Q1 FY2310 Aug 20220.0%+1.9%+13.6%1.1×
Q4 FY2226 May 2022+2.3%+7.6%+2.5%0.5×
Q3 FY2212 Feb 2022-1.6%-0.4%-6.6%1.2×
Q2 FY2212 Nov 2021+5.9%+0.3%+11.3%3.4×
Q1 FY2211 Aug 2021-1.0%+13.0%+25.6%2.5×
Q4 FY212 Jun 2021-0.4%+7.1%+10.5%0.6×
Q3 FY216 Feb 2021+1.3%+8.9%+10.8%2.5×
Q2 FY2112 Nov 2020-2.5%+2.2%+14.6%1.3×
Average+0.2%+1.8%+5.3%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q1 FY27

CSV
Revenue YoY+16.7%
Profit YoY+4.9%
Interest cost YoY+28.2%
Revenue QoQ+10.4%
Profit QoQ-5.6%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+24.0%+22.2%+21.5%+21.8%——
Profit+17.6%+7.6%+23.3%+35.4%——

Key data

CSV
Open921.55
Day range892.25 – 921.60
52-week range892.25 – 1,221.90
From 52w high-26.1%
RSI (14)26.6
ATR (14)29.56
Volume24.07L
Avg volume (20D)29.41L
Rel volume0.82×
Volatility (1Y)27.1%
Turnover₹217.2Cr
SMA 50 / 2001,026.29 / 1,031.51

Delivery percentage

Latest · 6 Oct 202649.7%
20-day avg55.3%
1-year avg58.2%
Percentile (own history)15th
Range22.5–100.0%
Sessions1,513

Over the last 20 sessions MAXHEALTH settled 55.3% of its traded quantity, which is above average for an NSE equity. Its one-year average is 58.2%, so recent sessions are running 3.0 points lower than usual. The latest session ranks higher than 15% of the 1,513 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

IndustryHospital
PeersAPOLLOHOSPFORTISYATHARTHASTERDMMANIPALHOSLALPATHLAB

Performance returns

CSV
1D1W1M3M6M1Y
Price-1.58%-9.76%-9.29%-19.30%-4.46%-19.66%

Valuation

CSV
Market cap₹87,841 Cr
P/E (TTM)60.3
EPS (TTM)14.97
Shares outstanding97.32Cr
Listed21 Aug 2020

Ownership

CSV
Promoter23.71%
Promoter Δ QoQ0.00 pp
Public76.29%
FII41.78%
DII29.96%
Pledged0.00%

Quarterly results · consolidated

CSV
Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue (₹ Cr)2,135.52,067.52,142.92,366.2
YoY chg+25.1%+10.7%+12.2%+16.7%
Net profit (₹ Cr)491.3300.9342.2323.0
YoY chg+74.3%+26.0%+7.3%+4.9%
Net margin23.0%14.6%16.0%13.6%
EPS5.023.093.503.30

Shareholding over time

CSV

By quarter

30 Jun 2026 · promoter 23.71% · public 76.29%
30 Sept 2021: promoter 60.91%31 Dec 2021: promoter 60.68%31 Mar 2022: promoter 50.64%30 Jun 2022: promoter 50.64%30 Sept 2022: promoter 23.80%31 Dec 2022: promoter 23.78%31 Mar 2023: promoter 23.77%30 Jun 2023: promoter 23.76%30 Sept 2023: promoter 23.76%31 Dec 2023: promoter 23.75%31 Mar 2024: promoter 23.75%30 Jun 2024: promoter 23.74%30 Sept 2024: promoter 23.74%31 Dec 2024: promoter 23.74%31 Mar 2025: promoter 23.74%30 Jun 2025: promoter 23.74%30 Sept 2025: promoter 23.74%31 Dec 2025: promoter 23.72%31 Mar 2026: promoter 23.71%30 Jun 2026: promoter 23.71%
2021-092026-06
  • Promoter
  • Public and others
Promoter
23.71%
Public
76.29%
Promoter change
0.00 pp
Filed
17 Jul 2026
FII
41.78%
DII
29.96%
Promoter pledged
0.00%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV
₹ crore, as filed
 Q2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27
Revenue from operations1,363.21,335.01,422.91,543.01,707.51,868.31,909.72,027.62,135.52,067.52,142.92,366.2
Other income45.546.045.334.740.833.346.936.532.945.447.840.5
Total income1,408.61,381.01,468.21,577.61,748.31,901.61,956.72,064.12,168.42,112.92,190.72,406.7
Total expenses1,042.21,021.31,132.41,256.31,374.61,519.11,554.21,663.71,722.31,700.11,726.11,970.4
└ Finance costs8.511.220.723.933.552.455.254.953.959.766.771.0
└ Depreciation57.961.070.376.984.297.5100.8104.1108.1111.3123.0131.7
Profit before tax366.4359.7335.7321.3373.7308.9402.5400.4446.0364.5464.6436.3
Tax expense89.770.384.285.091.970.183.592.5(45.3)63.6122.4113.4
Net profit276.7289.3251.5236.3281.8238.8319.0308.0491.3300.9342.2323.0
EPS2.852.982.592.432.902.463.283.175.053.103.523.32
Net margin20.30%21.67%17.68%15.31%16.50%12.78%16.70%15.19%23.01%14.55%15.97%13.65%
PBT margin26.88%26.94%23.59%20.82%21.89%16.53%21.08%19.75%20.89%17.63%21.68%18.44%
Tax rate24.49%19.56%25.08%26.47%24.59%22.69%20.75%23.09%-10.15%17.45%26.34%25.98%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 13 Aug 2026.

MAXHEALTH at a glance

  • MAXHEALTH closed at ₹902.5 on 6 Oct 2026, -1.58% on the day, -19.7% over one year, 26.1% below its 52-week high of ₹1,221.9.
  • Delivery was 49.7% of traded quantity on 6 Oct 2026, the 15th percentile of its own 1,513 sessions with a reading (20-session average 55.3%, 1-year average 58.2%).
  • Market capitalisation is ₹87,841 crore at a trailing P/E of 60.3 (trailing EPS ₹14.97).
  • Q1 FY27 results (consolidated, filed 13 Aug 2026): revenue ₹2,366 crore (+16.7% year on year), net profit ₹323 crore (+4.9%); the price moved -0.5% on the first session after.
  • Promoters held 23.71% at 30 Jun 2026, unchanged on the previous filing.
  • Q2 FY27 results are expected between 1 Nov 2026 and 14 Nov 2026, going by past filing dates — an estimate, not an announcement.

About

CSV
Macro sectorHealthcare
Basic industryHospital
ISININE027H01010
SeriesEQ
Listed21 Aug 2020
History from21 Aug 2020
Sessions1,518
Turnover rank#87

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.

More in Healthcare Services

CSV

All Healthcare Services stocks on the NSEAll Healthcare stocks on the NSE